InterPATH-001 trial in progress: Adjuvant V940 (mRNA-4157) with pembrolizumab versus placebo in patients with high-risk stage II-IV melanoma - J.S. Weber; J.J. Luke; M.S. Carlino; M.A. Khattak; R. Meehan; M. Brown; J. Zhang; C. Krepler; J.P. Duic; G.V. Long (EJC Skin Cancer)